Valeant ($VRX) investors eager for answers will get some on March 15, the company promised. That's when it now intends to release preliminary quarterly results--which it delayed last week for a variety of reasons, including pneumonia-stricken CEO J. Michael Pearson's comeback--and it'll hold a conference call that day, too. Release | More
@FiercePharma: Heska's topsy-turvy year ends on a high note as earnings beat estimates. More from FierceAnimalHealth | Follow @FiercePharma
@CarlyHFierce: Victoza comes up big for Novo with key heart-risk lowering data. More | Follow @CarlyHFierce
> In some statistical evidence for common sense, a physician survey found that doctors would be most likely to prescribe biosimilar drugs at bigger discounts. Report
> Valeant ($VRX) CEO Michael Pearson's one-on-one calls with handpicked analysts last week raised eyebrows among other analysts and investors who are looking for more transparency at the embattled company. Report
> New Jersey's Alvogen has agreed to buy generic drugmaker County Line Pharmaceuticals. Release
> Accord Healthcare is bringing up to 100 new jobs to a Newcastle, U.K. site where Sanofi ($SNY) ceased operations last year. More
Medical Device News
@FierceMedDev: ICYMI: Siemens Healthcare CEO: restructured unit 'hungry' for M&A deals. Article | Follow @FierceMedDev
@EmilyWFierce: UPDATED: AZ stokes $45B sales hopes with expanded approval for breast cancer drug Faslodex. More | Follow @EmilyWFierce
> FDA nod for smart contact lens that continuously monitors eye pressure changes in glaucoma. More
> Next up on Thermo Fisher's to-do list? Some serious M&A: Analyst. Report
> Senators butt heads over proposed device (and drug) industry regulatory overhaul. Article
Biotech News
@FierceBiotech: Celldex's cancer vaccine Rintega implodes in glioblastoma PhIII. News | Follow @FierceBiotech
@JohnCFierce: AbbVie hands over $595M upfront to partner with Boehringer on PhIII psoriasis drug. Report | Follow @JohnCFierce
> Bristol-Myers prints a pair of 'Golden Tickets' for Cambridge biotech startups. Report
> Europe takes a page from the FDA with new speedy approval program. Story
> Aimmune's peanut allergy drug clears Phase II on the way to a pivotal test. Article
Pharma Marketing News
> With Allergan's Kybella campaign, Khloé Kardashian follows sister Kim into pharma land. Report
> New privacy-friendly partnership taps consumer data to help pharma target mobile marketing. Item
> J&J, AbbVie swell Imbruvica patient pool with first-line FDA nod in CLL. More
> DTC challenges mount as senators roll out bill to yank tax deduction. Story
> New privacy-friendly partnership taps consumer data to help pharma target mobile marketing. Article
Animal Health News
> Kindred projects increased spending as it preps for first commercial product. Item
> VCA adds 56 veterinary clinics by snapping up $344M stake in Las Vegas chain. Report
> Heska's topsy-turvy year ends on a high note as record earnings beat estimates. More
> Under pressure from activists, In-N-Out Burger jumps on antibiotic-free bandwagon. Story
> Zoetis launches first genomic test for predicting common diseases in Holsteins. Article
Biotech IT News
> Bristol-Myers signs deal to use Veeva tools for regulatory information. News
> U.K. firms team up to develop mental health-tracking wearable devices. Report
> GSK extends business process analytics contract to 2020. Story
> George Church's Veritas starts $999 whole-genome sequencing service. Item
> IPhone-based Parkinson's study shares 6 months of data on 9,500 participants. Article
And Finally... A study has identified a link between an ADHD med and diminished bone health in kids. More